Recently, Sørensen et al. showed that CCL2 levels are similar in the CSF of MS compared to optic neuritis patients and in peripheral monocytes of MS compared to healthy controls, suggesting that this chemokine may have a limited role in MS pathogenesis [141]. The gene discussed is CCL2; the disease is myeloid sarcoma.